These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30663132)

  • 1. Accounting for a decaying correlation structure in cluster randomized trials with continuous recruitment.
    Grantham KL; Kasza J; Heritier S; Hemming K; Forbes AB
    Stat Med; 2019 May; 38(11):1918-1934. PubMed ID: 30663132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of non-uniform correlation structure on sample size and power in multiple-period cluster randomised trials.
    Kasza J; Hemming K; Hooper R; Matthews J; Forbes AB
    Stat Methods Med Res; 2019 Mar; 28(3):703-716. PubMed ID: 29027505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of varying cluster size in cross-sectional stepped-wedge cluster randomised trials.
    Martin JT; Hemming K; Girling A
    BMC Med Res Methodol; 2019 Jun; 19(1):123. PubMed ID: 31200640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An imbalance in cluster sizes does not lead to notable loss of power in cross-sectional, stepped-wedge cluster randomised trials with a continuous outcome.
    Kristunas CA; Smith KL; Gray LJ
    Trials; 2017 Mar; 18(1):109. PubMed ID: 28270224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inference for the treatment effect in multiple-period cluster randomised trials when random effect correlation structure is misspecified.
    Kasza J; Forbes AB
    Stat Methods Med Res; 2019; 28(10-11):3112-3122. PubMed ID: 30189794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of unequal cluster sizes for GEE analyses of stepped wedge cluster randomized trials with binary outcomes.
    Tian Z; Preisser JS; Esserman D; Turner EL; Rathouz PJ; Li F
    Biom J; 2022 Mar; 64(3):419-439. PubMed ID: 34596912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. swdpwr: A SAS macro and an R package for power calculations in stepped wedge cluster randomized trials.
    Chen J; Zhou X; Li F; Spiegelman D
    Comput Methods Programs Biomed; 2022 Jan; 213():106522. PubMed ID: 34818620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hybrid approach to comparing parallel-group and stepped-wedge cluster-randomized trials with a continuous primary outcome when there is uncertainty in the intra-cluster correlation.
    Sarkodie SK; Wason JM; Grayling MJ
    Clin Trials; 2023 Feb; 20(1):59-70. PubMed ID: 36086822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five questions to consider before conducting a stepped wedge trial.
    Hargreaves JR; Copas AJ; Beard E; Osrin D; Lewis JJ; Davey C; Thompson JA; Baio G; Fielding KL; Prost A
    Trials; 2015 Aug; 16():350. PubMed ID: 26279013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cluster randomized crossover trial: The effects of attrition in the AB/BA design and how to account for it in sample size calculations.
    Moerbeek M
    Clin Trials; 2020 Aug; 17(4):420-429. PubMed ID: 32191129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and analysis considerations for cohort stepped wedge cluster randomized trials with a decay correlation structure.
    Li F
    Stat Med; 2020 Feb; 39(4):438-455. PubMed ID: 31797438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of information criteria for selecting a correlation structure for longitudinal cluster randomised trials.
    Rezaei-Darzi E; Kasza J; Forbes A; Bowden R
    Clin Trials; 2022 Jun; 19(3):316-325. PubMed ID: 35706343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does it decay? Obtaining decaying correlation parameter values from previously analysed cluster randomised trials.
    Kasza J; Bowden R; Ouyang Y; Taljaard M; Forbes AB
    Stat Methods Med Res; 2023 Nov; 32(11):2123-2134. PubMed ID: 37589088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cluster randomised crossover trials with binary data and unbalanced cluster sizes: application to studies of near-universal interventions in intensive care.
    Forbes AB; Akram M; Pilcher D; Cooper J; Bellomo R
    Clin Trials; 2015 Feb; 12(1):34-44. PubMed ID: 25475880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The optimal design of stepped wedge trials with equal allocation to sequences and a comparison to other trial designs.
    Thompson JA; Fielding K; Hargreaves J; Copas A
    Clin Trials; 2017 Dec; 14(6):639-647. PubMed ID: 28797179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size calculation for stepped wedge and other longitudinal cluster randomised trials.
    Hooper R; Teerenstra S; de Hoop E; Eldridge S
    Stat Med; 2016 Nov; 35(26):4718-4728. PubMed ID: 27350420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative efficiency of unequal cluster sizes in stepped wedge and other trial designs under longitudinal or cross-sectional sampling.
    Girling AJ
    Stat Med; 2018 Dec; 37(30):4652-4664. PubMed ID: 30209812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating intra-cluster correlation coefficients for planning longitudinal cluster randomized trials: a tutorial.
    Ouyang Y; Hemming K; Li F; Taljaard M
    Int J Epidemiol; 2023 Oct; 52(5):1634-1647. PubMed ID: 37196320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substantial risks associated with few clusters in cluster randomized and stepped wedge designs.
    Taljaard M; Teerenstra S; Ivers NM; Fergusson DA
    Clin Trials; 2016 Aug; 13(4):459-63. PubMed ID: 26940696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accounting for complex intracluster correlations in longitudinal cluster randomized trials: a case study in malaria vector control.
    Ouyang Y; Kulkarni MA; Protopopoff N; Li F; Taljaard M
    BMC Med Res Methodol; 2023 Mar; 23(1):64. PubMed ID: 36932347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.